Welcome to our dedicated page for CRH PUBLIC CO SEC filings (Ticker: CRH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CRH PUBLIC CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CRH PUBLIC CO's regulatory disclosures and financial reporting.
CRH plc reported that it furnished a press release with financial results for the fiscal quarter ended September 30, 2025, and separately announced a quarterly dividend. Both announcements were issued on November 5, 2025, with the results release furnished as Exhibit 99.1 and the dividend release as Exhibit 99.2.
The company will host an earnings conference call and webcast on November 6, 2025 at 8:00 a.m. EST. Registration is available at www.crh.com/investors. The results information was furnished under Item 2.02 and is not deemed filed under the Exchange Act.
CRH plc filed an 8-K disclosing documentation for a new note offering and related legal opinions. The filing cites an Underwriting Agreement dated October 6, 2025 and references an Indenture dated May 21, 2024. An Officer's Certificate dated October 9, 2025 sets forth terms for three series of guaranteed notes: 4.400% due 2031, 5.000% due 2036 and 5.600% due 2056, with forms of the notes included.
Legal opinions from Arthur Cox LLP and Sullivan & Cromwell LLP and their consents are included, and the filing embeds the Cover Page Interactive Data File. The submission is signed by Nancy Buese, Chief Financial Officer.
CRH plc is offering three series of senior notes totaling $1,000,000,000 for the combined issuance: $500,000,000 of 2056 notes and two equal $1,000,000,000-series references reflecting allocation across maturities shown in the supplement. Specific series principal figures shown include multiple blocks of $141,667,000, $70,833,000, $67,500,000, and tranche totals of $1,000,000,000, $1,000,000,000 and $500,000,000. Each series accrues interest on a 360-day year of twelve 30-day months and will pay interest semiannually to record dates on January 25 and July 25.
Each series is redeemable at the issuer’s option on or after its Par Call Date at 100% of principal plus accrued interest. The supplement references tax and withholding certification (Forms W-8BEN / W-8BEN-E and W-8ECI) for non-U.S. holders and describes settlement mechanics (T+3 initial settlement, same-day funds for DTC participants, Clearstream/Euroclear procedures). The document incorporates CRH’s historical SEC filings by reference for additional risk and financial detail.
CRH plc is offering debt securities through a prospectus supplement that incorporates the company’s prior SEC filings by reference, including its Form 10-K for the year ended December 31, 2024 (filed February 26, 2025) and subsequent periodic reports filed through August 6, 2025 and other dates listed. The supplement describes terms for one or more series of Notes: interest is calculated on a 360-day year of twelve 30-day months, accrues from the Issue Date, and the issuer may redeem the Notes at par (100% of principal) plus accrued interest on or after the Notes’ Par Call Date.
The document explains settlement mechanics (initial T+3 with same-day funds requirements for some facilities), non-U.S. holder tax documentation requirements (IRS W-8 forms and Form 1042-S reporting), and lists underwriters and pages where specific disclosures appear in the supplement. The filing includes a tabular snapshot with several monetary line items including $2,876, $14,642, and a total of $39,054, presented as "Actual" and "As Adjusted" figures as of June 30, 2025.
Patrick Decker joined CRH plc's board as a non-management director and reported initial beneficial ownership. He directly holds 212 ordinary shares and received a pro rata, time-based Restricted Stock Unit award representing 932 RSUs, each convertible into one ordinary share. The RSUs reflect service from October 1, 2025, through the 2026 Annual General Meeting and are scheduled to fully vest in May 2026. Dividend equivalents will be reported when the award vests.
CRH plc filed a Form 8-K reporting the submission of exhibitable materials tied to its Investor Day on September 30, 2025. The filing lists a press release and multiple Investor Day presentations covering Growth, Performance, Roads, and Water, plus the cover page interactive data file formatted in Inline XBRL. The 8-K is signed by Nancy Buese. No financial results, guidance, transaction details, or other substantive metrics are included in the provided text, only the exhibit list and dates.
CRH plc's Board expanded from 12 to 13 members and appointed Patrick Decker as a non-management Director effective October 1, 2025. Mr. Decker will receive compensation under CRH's non-management Director program, including a pro rata Restricted Stock Unit (RSU) grant covering his service through the Annual General Meeting in 2026. The filing states Mr. Decker has no family relationship with current directors or executives and is not party to transactions requiring disclosure under Regulation S-K Item 404(a). It is anticipated he will enter an indemnification agreement in the same form CRH uses for its directors and officers. The Company also issued a press release on September 9, 2025 announcing the appointment.